Briggs Morrison

Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more
Endpoints
Thu, 03/7/19 - 09:43 pm
Syndax
Briggs Morrison
clinical trials
entinostat
AstraZeneca R&D executive Morrison to lead cancer firm Syndax
Yahoo/Reuters
Mon, 06/15/15 - 09:28 am
AstraZeneca
R&D
cancer
Briggs Morrison
Syndax